Crossmark

[Translated article] The Utility of long-Term Number Needed to Treat to Evaluate Interleukin 17 and 23 Inhibitor Therapies in the Treatment of Moderate to Severe Plaque Psoriasis

Crossref DOI link: https://doi.org/10.1016/j.ad.2023.03.019

Published Print: 2024-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

González-Domínguez, A.

García-Agua, N.

Dauden, E.

Ventayol-Bosch, P.
License Information

Text and Data Mining valid from 2024-04-01

Text and Data Mining valid from 2024-04-01

Version of Record valid from 2024-02-06
More Information

This article is maintained by: Elsevier

Article Title: [Translated article] The Utility of long-Term Number Needed to Treat to Evaluate Interleukin 17 and 23 Inhibitor Therapies in the Treatment of Moderate to Severe Plaque Psoriasis

Journal Title: Actas Dermo-Sifiliográficas

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ad.2023.03.019

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.ad.2023.03.012

Content Type: simple-article

Copyright: © 2023 AEDV. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below